U.S. Life Sciences Stock News

NYSE:IQV
NYSE:IQVLife Sciences

IQVIA (IQV) EPS Surge To US$3.02 Tests Bearish Margin Concerns

IQVIA Holdings (IQV) just closed out FY 2025 with Q4 revenue of US$4.4b and basic EPS of US$3.02, capping a year in which trailing 12 month revenue came in at US$16.3b and EPS reached US$7.91. Over the past few quarters, the company has seen revenue move from US$3.8b in Q1 2025 to US$4.1b in Q3 2025 and US$4.4b in Q4 2025. Quarterly EPS went from US$1.42 to US$1.94 to US$3.02, setting the stage for investors to weigh that earnings trajectory against an 8.3% net margin that sits below last...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

Axcelis Technologies (ACLS) Margin Compression Tests Bullish Silicon Carbide Growth Narrative

Axcelis Technologies (ACLS) just wrapped up FY 2025 with Q4 revenue of US$238.3 million and basic EPS of US$1.11, alongside trailing twelve month revenue of US$839.0 million and EPS of US$3.81 that frame the latest quarter in a fuller earnings picture. Over recent periods, the company has seen quarterly revenue range from US$192.6 million to US$238.3 million and quarterly EPS move between US$0.83 and US$1.11. During the same time, trailing twelve month revenue moved from US$958.1 million to...
NYSE:UCB
NYSE:UCBBanks

United Community Banks (UCB) Net Interest Margin Gain Backs Bullish Profitability Narrative

United Community Banks (UCB) has wrapped up FY 2025 with fourth quarter revenue of US$264.7 million and basic EPS of US$0.71, supported by trailing twelve month revenue of US$1.0 billion and EPS of US$2.62. The bank has seen revenue move from US$901.2 million and EPS of US$2.04 over the prior trailing period to US$1.0 billion and EPS of US$2.62 most recently, alongside a net profit margin of 31.4% versus 27.1% a year earlier. This puts the focus firmly on how efficiently it is turning its top...
NYSE:WAT
NYSE:WATLife Sciences

Waters Targets Growth With MaxPeak Columns And Four-Division Realignment

Waters Corporation (NYSE:WAT) introduced new high-sensitivity liquid chromatography columns featuring MaxPeak Premier Technology. The company completed a realignment of its operations into four focused divisions aimed at adjacent high-growth markets. Waters, a long-established player in analytical instruments and laboratory solutions, is using this product launch and business realignment to sharpen its role in analytical sciences and diagnostics. The new columns with MaxPeak Premier...
NYSE:QUAD
NYSE:QUADCommercial Services

Quad Graphics (QUAD) Return To Profitability Tests Bullish Margin Expansion Narrative

Quad/Graphics (QUAD) closed out FY 2025 with fourth quarter revenue of $630.6 million and basic EPS of $0.23, alongside net income of $11.1 million. Over the past few quarters, the company has seen revenue move from $708.4 million and EPS of $0.10 in Q4 2024 through $629.4 million and $0.12 in Q1 2025, $571.9 million and roughly breakeven EPS in Q2 2025, then $588 million and $0.21 in Q3 2025. This frames a year where profitability settled in at a trailing twelve month EPS of $0.57 on $2.4...
NYSE:DINO
NYSE:DINOOil and Gas

HF Sinclair (DINO) Q3 EPS Rebound Tests Bearish Volatility Narrative

HF Sinclair (DINO) has just posted its FY 2025 third quarter numbers, with revenue of US$7.3b and basic EPS of US$2.16, set against trailing 12 month earnings growth of 18.7%. The company has seen revenue move from US$7.2b in Q3 2024 to US$7.3b in Q3 2025, while quarterly EPS shifted from a loss of US$0.40 to EPS of US$2.16. The trailing net profit margin sits at 1.5% versus 1.1% last year, giving investors a clearer view of how the earnings profile is shaping up. Taken together, these...
NYSE:NPO
NYSE:NPOMachinery

Enpro (NPO) Margin Improvement And 59.7% Earnings Growth Reinforce Bullish Narratives

Enpro (NPO) has put up another solid set of numbers for FY 2025 so far, with Q3 revenue at US$286.6 million and basic EPS of US$1.02. Trailing twelve month EPS sits at US$4.11 on US$1.1 billion of revenue. The company has seen revenue move from US$1.04 billion with EPS of US$2.58 over the twelve months to Q3 2024 to US$1.1 billion with EPS of US$4.11 over the latest twelve month window. This has come alongside earnings growth of 59.7% and an uptick in net profit margin from 5.2% to 7.8%,...
NasdaqGM:BBNX
NasdaqGM:BBNXMedical Equipment

Beta Bionics (BBNX) Revenue Growth Outpaces Persistent Losses And Tests Bullish Narratives

Beta Bionics (BBNX) just closed out FY 2025 with Q4 revenue of US$32.1 million and a net loss of US$13.5 million, which translated to EPS of US$0.30 loss, while trailing 12 month revenue reached US$100.3 million alongside a net loss of US$73.2 million and EPS of US$1.81 loss. Over recent quarters the company has seen revenue move from US$17.6 million and EPS of US$0.93 loss in Q1 2025 to US$27.3 million and EPS of US$0.33 loss in Q3 2025, before landing at the latest Q4 run rate. For...
NasdaqGS:LBTY.A
NasdaqGS:LBTY.ATelecom

Liberty Global (LBTY.A) Quarterly Loss Narrows Yet LTM US$1.9b Loss Reinforces Bearish Narratives

Liberty Global (LBTY.A) has reported another tough set of numbers for FY 2025, with Q3 revenue of US$1,207.1 million and a basic EPS loss of US$0.27, alongside trailing 12 month revenue of US$4.8 billion and a basic EPS loss of US$5.47. Over recent periods, the company has seen revenue move from US$1,069.5 million in Q3 2024 to US$1,207.1 million in Q3 2025, while EPS has shifted from a loss of US$4.0 in Q3 2024 to a loss of US$0.27 in Q3 2025. Overall, the latest figures keep the spotlight...
NasdaqGS:HCKT
NasdaqGS:HCKTIT

Hackett Group (HCKT) Margin Compression Challenges Bullish Gen AI Earnings Narrative

Hackett Group FY 2025 earnings snapshot Hackett Group (HCKT) has wrapped up FY 2025 with fourth quarter revenue of about US$75.8 million and basic EPS of US$0.21, alongside trailing twelve month revenue of US$305.6 million and EPS of US$0.47 that sit against a net profit margin of 4.2% for the period. Over recent quarters, the company has seen revenue move between US$72.2 million and US$77.6 million, while quarterly EPS ranged from US$0.06 to US$0.31 and trailing EPS shifted from US$1.23 to...
NasdaqGS:BELF.A
NasdaqGS:BELF.AElectronic

Bel Fuse (BELF.A) Quarterly Loss Tests Bullish Earnings Growth Narrative

Bel Fuse (BELF.A) has wrapped up FY 2025 with Q4 revenue of US$175.9 million and a basic EPS loss of US$0.43, while trailing twelve month figures show revenue of US$675.5 million and EPS of US$4.87, underpinned by trailing earnings growth of 50.2% year over year. The company has seen revenue step up from US$534.8 million on a trailing basis in Q4 2024 to US$675.5 million in Q4 2025, with net income rising from US$41.0 million to US$61.5 million over the same period, setting the stage for...
NYSE:CE
NYSE:CEChemicals

Celanese (CE) Returns To Q4 Profit But Trailing US$1.1b Loss Tests Bullish Narratives

Celanese (CE) has wrapped up FY 2025 with fourth quarter revenue of US$2.2 billion and basic EPS of US$0.23, against a trailing twelve month picture that includes a basic EPS loss of US$10.45 on revenue of US$9.5 billion. Over recent periods, quarterly revenue has ranged from US$2.4 billion to US$2.5 billion, while basic EPS has swung between a loss of US$12.39 and a profit of US$1.86. This sets up a story where investors are watching how far improving headline numbers can translate into...
NasdaqGS:SABR
NasdaqGS:SABRHospitality

Sabre (SABR) Turns EPS Positive In Q3 2025 Testing Profitability Narratives

Sabre’s latest earnings snapshot Sabre (SABR) has reported its FY 2025 third quarter with total revenue of US$715.2 million and basic EPS of US$0.12, alongside earnings from discontinued operations of US$800.3 million and net income from continuing operations of US$48.4 million. The company has seen revenue hold in a tight band over recent periods, from US$691.3 million in Q3 2024 to US$714.7 million in Q4 2024, US$702.1 million in Q1 2025, US$687.1 million in Q2 2025, and now US$715.2...
NYSE:IRT
NYSE:IRTResidential REITs

Independence Realty Trust (IRT) FFO Stability Supports Bullish Narratives Despite Earnings Volatility

Independence Realty Trust (IRT) closed out FY 2025 with fourth quarter revenue of US$169.5 million and basic EPS of US$0.14, while funds from operations reached US$79.4 million, giving investors a clean snapshot of its latest run rate. The company has seen quarterly revenue move from US$163.7 million and basic EPS of roughly breakeven in Q4 2024 to US$169.5 million and EPS of US$0.14 in Q4 2025. Trailing 12 month revenue of US$668.8 million and basic EPS of US$0.24 frame the year in...
NYSE:DRD
NYSE:DRDMetals and Mining

DRDGOLD (NYSE:DRD) Margin Surge To 28.5% Tests Bearish Profitability Narratives

DRDGOLD (NYSE:DRD) has put up another firm set of numbers for H1 2026, with H2 2025 revenue at R4.1b and basic EPS of R14.76 sitting on top of R1.3b in net income, while the trailing twelve month line shows revenue of R7.9b and basic EPS of R26.01 backed by R2.2b in net income. The company has seen revenue move from R3.3b in H2 2024 to R3.8b in H1 2025 and then R4.1b in H2 2025, alongside basic EPS stepping from R8.58 to R11.26 and then R14.76. This progression sets a clear earnings rhythm...
NYSE:TRTX
NYSE:TRTXMortgage REITs

TPG RE Finance Trust (TRTX) Margin Compression Challenges Longstanding Income Bull Case

TPG RE Finance Trust (TRTX) closed out FY 2025 with Q4 revenue of US$23.8 million and basic EPS of roughly US$0.00, capping a year where quarterly revenue moved between US$23.8 million and US$40.4 million while EPS ranged from about US$0.00 to US$0.23. Across the last six reported quarters, revenue has run between US$23.8 million and US$40.4 million with EPS between roughly US$0.00 and US$0.23, giving investors a clear view of how income streams have shifted through recent reporting periods...
NasdaqGS:DOX
NasdaqGS:DOXIT

Amdocs (DOX) Margin Improvement To 12.5% Tests Longstanding Earnings Skepticism

Amdocs (DOX) has opened Q1 2026 with revenue of US$1.2 billion and basic EPS of US$1.46, setting the tone for investors focused on how profit is tracking against prior quarters. The company has seen quarterly revenue hold around the US$1.1 billion mark over the past year, from US$1.11 billion in Q1 2025 to US$1.16 billion in Q1 2026. Over the same period, basic EPS moved from US$1.34 to US$1.46, and trailing twelve month EPS sits at US$5.19. With net profit margins having improved over the...
NYSE:TNL
NYSE:TNLHospitality

Travel + Leisure (TNL) Net Margin Near 10% Tests Bullish Durability Narratives

Travel + Leisure (TNL) has posted its FY 2025 third quarter results with revenue of US$1,044 million and basic EPS of US$1.70, alongside trailing twelve month revenue of US$3.97 billion and EPS of US$6.14 that frame the latest quarter in a broader context. The company has seen quarterly revenue move from US$971 million in Q4 2024 to US$1,044 million in Q3 2025, while basic EPS has ranged between US$1.09 and US$1.73 across that stretch. This sets up a picture of consistent earnings power and...
NYSE:TOL
NYSE:TOLConsumer Durables

Toll Brothers (TOL) Margin Compression Challenges Bullish Luxury Housing Narratives

Toll Brothers (TOL) opened its 2026 fiscal year with Q1 revenue of US$2.1b and basic EPS of US$2.20, setting the tone for how its upscale housing demand is feeding through to the bottom line. The company has seen quarterly revenue move from US$1,859.1m and EPS of US$1.76 in Q1 2025 to US$2,145.6m and EPS of US$2.20 in Q1 2026. Trailing 12 month EPS sits at US$14.12 on revenue of US$11.3b, giving investors a clear view of scale. With a trailing net margin of 12.3% versus 14.0% last year, the...
NasdaqGS:RUSH.A
NasdaqGS:RUSH.ATrade Distributors

Rush Enterprises (RUSH.A) Margin Compression Challenges Bullish EPS Growth Narrative

Rush Enterprises (RUSHA) closed out FY 2025 with Q4 revenue of US$1.8 billion and basic EPS of US$0.83, alongside net income of US$64.3 million, setting the tone for how the year’s trading performance lands for shareholders. Over the last six quarters, the company has seen quarterly revenue move between US$1.8 billion and US$2.0 billion, while basic EPS ranged from US$0.76 to just under US$1.00. This gives a clear view of how top line and per share earnings have tracked together. With...
NasdaqGS:IOSP
NasdaqGS:IOSPChemicals

Innospec (IOSP) Margin Rebound And EPS Surge Challenge Earnings Skeptics

Innospec (IOSP) has wrapped up FY 2025 with Q4 revenue of US$455.6 million and basic EPS of US$1.91, alongside trailing twelve month revenue of US$1.8 billion and EPS of US$4.69 that sit against a year of sharply higher earnings growth and a net margin of 6.6% versus 1.9% a year earlier. Over recent periods, revenue has ranged from US$439.7 million to US$466.8 million per quarter, while quarterly EPS has moved between a loss of US$2.82 and a gain of US$1.91. This sets the stage for investors...
OTCPK:ELTP
OTCPK:ELTPPharmaceuticals

Elite Pharmaceuticals (OTCPK:ELTP) Profit Turnaround Challenges Bearish Earnings Quality Narratives

Elite Pharmaceuticals (ELTP) just posted its Q3 2026 numbers, with revenue of US$31.6 million, basic EPS of US$0.017, and net income of US$18.6 million, while on a trailing twelve month basis revenue sits at US$140.1 million and EPS at US$0.040. Over the past few quarters, the company has seen revenue move between US$14.4 million and US$40.2 million per quarter, with basic EPS ranging from a loss of US$0.010 to a profit of US$0.018, and trailing twelve month EPS shifting from a loss of...
NasdaqGS:COHU
NasdaqGS:COHUSemiconductor

Cohu (COHU) Revenue Growth Story Tested By Persistent EPS Losses In FY 2025 Results

How Cohu’s FY 2025 Numbers Set the Stage for the Next Chapter Cohu (COHU) closed FY 2025 with Q4 revenue of US$122.2 million and a basic EPS loss of US$0.48, alongside trailing twelve month revenue of US$453.0 million and an EPS loss of US$1.59. Over recent quarters, the company has seen revenue move from US$94.1 million in Q4 2024 to US$96.8 million in Q1 2025, US$107.7 million in Q2 2025, US$126.2 million in Q3 2025, and US$122.2 million in Q4 2025, while quarterly EPS losses ranged between...